Li‐Xing Yang

965 total citations · 1 hit paper
24 papers, 769 citations indexed

About

Li‐Xing Yang is a scholar working on Biomedical Engineering, Materials Chemistry and Molecular Biology. According to data from OpenAlex, Li‐Xing Yang has authored 24 papers receiving a total of 769 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Biomedical Engineering, 9 papers in Materials Chemistry and 8 papers in Molecular Biology. Recurrent topics in Li‐Xing Yang's work include Nanoparticles: synthesis and applications (7 papers), Environmental remediation with nanomaterials (5 papers) and Nanoplatforms for cancer theranostics (5 papers). Li‐Xing Yang is often cited by papers focused on Nanoparticles: synthesis and applications (7 papers), Environmental remediation with nanomaterials (5 papers) and Nanoplatforms for cancer theranostics (5 papers). Li‐Xing Yang collaborates with scholars based in Taiwan, Australia and China. Li‐Xing Yang's co-authors include Dar-Bin Shieh, Pei‐Wen Wang, Yi‐Ching Wang, Dong‐Hwang Chen, Filip Braet, Kyle R. Ratinac, Pall Thordarson, Chih‐Chia Huang, Ya‐Na Wu and Dar‐Bin Shieh and has published in prestigious journals such as ACS Nano, Biomaterials and Scientific Reports.

In The Last Decade

Li‐Xing Yang

23 papers receiving 761 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

An innovative NRF2 nano-modulator induces lung cancer ferroptosis and elicits an immunostimulatory tumor microenvironment

2021 199 citations Pei‐Wen Wang, Li‐Xing Yang et al. Theranostics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Li‐Xing Yang Taiwan	15	278	267	227	205	138	24	769
Yaodong Jiang China	12	224 0.8×	263 1.0×	141 0.6×	84 0.4×	176 1.3×	25	799
Menglin Wu China	18	303 1.1×	163 0.6×	253 1.1×	83 0.4×	135 1.0×	53	807
Dan Lü China	19	290 1.0×	388 1.5×	109 0.5×	95 0.5×	64 0.5×	61	979
Zhen You China	16	233 0.8×	269 1.0×	269 1.2×	113 0.6×	68 0.5×	48	798
Ludovic Colombeau France	18	427 1.5×	179 0.7×	403 1.8×	324 1.6×	174 1.3×	29	1.1k
Shaohui Huang China	17	177 0.6×	250 0.9×	149 0.7×	77 0.4×	180 1.3×	38	930
Yongkang Yu China	16	484 1.7×	277 1.0×	224 1.0×	116 0.6×	187 1.4×	34	924
Parinaz Fathi United States	17	394 1.4×	299 1.1×	246 1.1×	84 0.4×	133 1.0×	28	864
Fangqin Xue China	15	286 1.0×	370 1.4×	168 0.7×	105 0.5×	58 0.4×	39	724
Xiaoyan Zou China	15	78 0.3×	265 1.0×	205 0.9×	130 0.6×	71 0.5×	26	866

Countries citing papers authored by Li‐Xing Yang

Since Specialization

Citations

This map shows the geographic impact of Li‐Xing Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li‐Xing Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li‐Xing Yang more than expected).

Fields of papers citing papers by Li‐Xing Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li‐Xing Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li‐Xing Yang. The network helps show where Li‐Xing Yang may publish in the future.

Co-authorship network of co-authors of Li‐Xing Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Li‐Xing Yang. A scholar is included among the top collaborators of Li‐Xing Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li‐Xing Yang. Li‐Xing Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hsu, Fei‐Ting, Yu‐Cheng Chin, Li‐Xing Yang, et al.. (2024). Harnessing the Power of Sugar-Based Nanoparticles: A Drug-Free Approach to Enhance Immune Checkpoint Inhibition against Glioblastoma and Pancreatic Cancer. ACS Nano. 18(42). 28764–28781. 15 indexed citations

Chen, Pei‐Jer, Ying Lu, Xiaoyu Lai, et al.. (2024). [Efficacy and prognostic factors of allogeneic hematopoietic stem cell transplantation in the treatment of secondary acute myeloid leukemia].. PubMed. 45(1). 41–47. 1 indexed citations

Yang, Li‐Xing, Zhi Ye, Tzu‐Chi Huang, et al.. (2023). Novel metal peroxide nanoboxes restrain Clostridioides difficile infection beyond the bactericidal and sporicidal activity. Bioengineering & Translational Medicine. 8(6). e10593–e10593. 2 indexed citations

Su, Wen‐Pin, Li‐Xing Yang, Zi‐Chun Chia, et al.. (2022). Polyaniline-Based Glyco-Condensation on Au Nanoparticles Enhances Immunotherapy in Lung Cancer. ACS Applied Materials & Interfaces. 14(21). 24144–24159. 26 indexed citations

Chin, Yu‐Cheng, Li‐Xing Yang, Fei‐Ting Hsu, et al.. (2022). Iron oxide@chlorophyll clustered nanoparticles eliminate bladder cancer by photodynamic immunotherapy-initiated ferroptosis and immunostimulation. Journal of Nanobiotechnology. 20(1). 373–373. 70 indexed citations

Chen, Rong-Jane, Hui‐Wen Chiu, Li‐Xing Yang, et al.. (2022). Nanoparticles augment the therapeutic window of RT and immunotherapy for treating cancers: pivotal role of autophagy. Theranostics. 13(1). 40–58. 17 indexed citations

Wu, Ya‐Na, Li‐Xing Yang, Pei‐Wen Wang, Filip Braet, & Dar‐Bin Shieh. (2022). From Microenvironment Remediation to Novel Anti-Cancer Strategy: The Emergence of Zero Valent Iron Nanoparticles. Pharmaceutics. 14(1). 99–99. 3 indexed citations

Wang, Pei‐Wen, et al.. (2021). An innovative NRF2 nano-modulator induces lung cancer ferroptosis and elicits an immunostimulatory tumor microenvironment. Theranostics. 11(14). 7072–7091. 199 indexed citations breakdown →

Chia, Zi‐Chun, Li‐Xing Yang, Fei‐Ting Hsu, et al.. (2021). In Situ Formation of Au-Glycopolymer Nanoparticles for Surface-Enhanced Raman Scattering-Based Biosensing and Single-Cell Immunity. ACS Applied Materials & Interfaces. 13(44). 52295–52307. 25 indexed citations

10.

Yang, Li‐Xing, Ya-Na Wu, Pei‐Wen Wang, et al.. (2020). Silver-coated zero-valent iron nanoparticles enhance cancer therapy in mice through lysosome-dependent dual programed cell death pathways: triggering simultaneous apoptosis and autophagy only in cancerous cells. Journal of Materials Chemistry B. 8(18). 4122–4131. 22 indexed citations

11.

Chin, Yu‐Cheng, Li‐Xing Yang, Shu‐Pao Wu, et al.. (2020). Multiplex antibacterial processes and risk in resistant phenotype by high oxidation-state nanoparticles: New killing process and mechanism investigations. Chemical Engineering Journal. 409. 128266–128266. 20 indexed citations

12.

Wu, Ya-Na, Dar-Bin Shieh, Li‐Xing Yang, et al.. (2018). Characterization of Iron Core–Gold Shell Nanoparticles for Anti-Cancer Treatments: Chemical and Structural Transformations During Storage and Use. Materials. 11(12). 2572–2572. 17 indexed citations

13.

Shieh, Dar‐Bin, Li‐Xing Yang, Wei‐Ting Lee, et al.. (2017). Zero-valent iron based nanoparticles selectively inhibit cancerous cells through mitochondria-mediated autophagy. 168–170. 1 indexed citations

14.

Lee, Wei-Ting, Ya-Na Wu, Yi‐Hsuan Chen, et al.. (2017). Octahedron Iron Oxide Nanocrystals Prohibited Clostridium difficile Spore Germination and Attenuated Local and Systemic Inflammation. Scientific Reports. 7(1). 8124–8124. 22 indexed citations

15.

Xu, Jie, Li‐Xing Yang, Xiaoxia Hu, et al.. (2014). The effect of polysaccharide types on adsorption properties of LbL assembled multilayer films. Soft Matter. 11(9). 1794–1799. 9 indexed citations

16.

Wang, Pei‐Wen, Mohammad Reza Abedini, Li‐Xing Yang, et al.. (2014). Gelsolin regulates cisplatin sensitivity in human head-and-neck cancer. International Journal of Cancer. 135(12). 2760–2769. 30 indexed citations

17.

Wu, Ya-Na, et al.. (2013). The anticancer properties of iron core–gold shell nanoparticles in colorectal cancer cells. International Journal of Nanomedicine. 8. 3321–3321. 23 indexed citations

18.

Wu, Ya‐Na, Li‐Xing Yang, I-Chen Li, et al.. (2011). The selective growth inhibition of oral cancer by iron core-gold shell nanoparticles through mitochondria-mediated autophagy. Biomaterials. 32(20). 4565–4573. 140 indexed citations

19.

Li, Tsung‐Ju, et al.. (2009). Synthesis of Polynucleotide Modified Gold Nanoparticles as a High Potent Anti‐Cancer Drug Carrier. Journal of the Chinese Chemical Society. 56(4). 703–708. 5 indexed citations

20.

Jiang, Bo, et al.. (2002). Hybrid polymerization of iso-butyl vinyl ether. Radiation Physics and Chemistry. 63(3-6). 469–473. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact